Compare UVE & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UVE | PSNL |
|---|---|---|
| Founded | 1990 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 1996 | 2019 |
| Metric | UVE | PSNL |
|---|---|---|
| Price | $42.91 | $16.24 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.44 |
| AVG Volume (30 Days) | 98.9K | ★ 1.8M |
| Earning Date | 10-22-2026 | 11-03-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 214.43 | 33.58 |
| EPS | ★ 3.93 | N/A |
| Revenue | ★ $1,603,915,000.00 | $69,648,000.00 |
| Revenue This Year | N/A | $18.40 |
| Revenue Next Year | N/A | $33.63 |
| P/E Ratio | $10.80 | ★ N/A |
| Revenue Growth | ★ 5.48 | N/A |
| 52 Week Low | $26.61 | $4.96 |
| 52 Week High | $45.15 | $18.89 |
| Indicator | UVE | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 41.85 | 51.30 |
| Support Level | $41.80 | $15.92 |
| Resistance Level | $43.87 | $16.39 |
| Average True Range (ATR) | 0.86 | 0.38 |
| MACD | -0.23 | -0.10 |
| Stochastic Oscillator | 18.52 | 34.50 |
Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.